Gene · 571
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging roles of ferroptosis in cardiovascular diseases. | Cell Death Discov | 2022 | 36127318 | PubTator, text mining | PubMed |
| Prediction of Functional Genes in Primary Varicose Great Saphenous Veins Using the lncRNA-miRNA-mRNA Network. | Comput Math Methods Med | 2022 | 36118829 | PubTator, text mining | PubMed |
| The mitotic regulator RCC2 promotes glucose metabolism through BACH1-dependent transcriptional upregulation of hexokinase II in glioma. | Cancer Lett | 2022 | 36116740 | PubTator, text mining | PubMed |
| Population Pharmacokinetic Modeling of Bedaquiline among Multidrug-Resistant Pulmonary Tuberculosis Patients from China. | Antimicrob Agents Chemother | 2022 | 36106884 | PubTator, text mining | PubMed |
| System Xc -/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. | Front Pharmacol | 2022 | 36105219 | PubTator, text mining | PubMed |
| Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma. | Genet Res (Camb) | 2022 | 36101742 | PubTator, text mining | PubMed |
| Erythrophagocytes in hemolytic anemia, wound healing, and cancer. | Trends Mol Med | 2022 | 36096988 | PubTator, text mining | PubMed |
| Sibling rivalry among the ZBTB transcription factor family: homodimers versus heterodimers. | Life Sci Alliance | 2022 | 36096675 | PubTator, text mining | PubMed |
| Lead exposure represses mitochondrial metabolism by activation of heme-binding protein BACH1 in differentiated SH-SY5Y cell. | Sci Total Environ | 2022 | 36096218 | PubTator, text mining | PubMed |
| The impact of COVID-19 on populations living at high altitude: Role of hypoxia-inducible factors (HIFs) signaling pathway in SARS-CoV-2 infection and replication. | Front Physiol | 2022 | 36091390 | PubTator, text mining | PubMed |
| Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability. | Front Oncol | 2022 | 36091172 | PubTator, text mining | PubMed |
| Biotinylation of an acetylenic tricyclic bis(cyanoenone) lowers its potency as an NRF2 activator while creating a novel activity against BACH1. | Free Radic Biol Med | 2022 | 36084789 | PubTator, text mining | PubMed |
| Simultaneous Targeting of Multiple oncomiRs with Phosphorothioate or PNA-Based Anti-miRs in Lymphoma Cell Lines. | Pharm Res | 2022 | 36071352 | PubTator, text mining | PubMed |
| Oxidative stress and inflammation regulation of sirtuins: New insights into common oral diseases. | Front Physiol | 2022 | 36060706 | PubTator, text mining | PubMed |
| The Hippo-YAP pathway in various cardiovascular diseases: Focusing on the inflammatory response. | Front Immunol | 2022 | 36059522 | PubTator, text mining | PubMed |
| The immunosuppression pathway of tumor-associated macrophages is controlled by heme oxygenase-1 in glioblastoma patients. | Int J Cancer | 2022 | 36054818 | PubTator, text mining | PubMed |
| LPS preconditioning of MSC-CM improves protection against hypoxia/reoxygenation-induced damage in H9c2 cells partly via HMGB1/Bach1 signalling. | Clin Exp Pharmacol Physiol | 2022 | 36052438 | PubTator, text mining | PubMed |
| Extracellular hemin is a reverse use-dependent gating modifier of cardiac voltage-gated Na+ channels. | Biol Chem | 2022 | 36038266 | PubTator, text mining | PubMed |
| Advances in molecular characterization of myeloid proliferations associated with Down syndrome. | Front Genet | 2022 | 36035173 | PubTator, text mining | PubMed |
| Proanthocyanidins Activate Nrf2/ARE Signaling Pathway in Intestinal Epithelial Cells by Inhibiting the Ubiquitinated Degradation of Nrf2. | Biomed Res Int | 2022 | 36033575 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/571/papers?page=32